(Q41056126)

26 September 2017

Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines (English)

1 reference

26 September 2017

0 references

1 reference

7

1 reference

26 September 2017

Anderson CP

1

1 reference

26 September 2017

Tsai J

2

1 reference

26 September 2017

Chan W

3

1 reference

26 September 2017

Park CK

4

1 reference

26 September 2017

Tian L

5

1 reference

26 September 2017

Lui RM

6

1 reference

26 September 2017

Reynolds CP

8

1 reference

26 September 2017

1 October 1997

1 reference

European Journal of Cancer

26 September 2017

1 reference

26 September 2017

33

1 reference

26 September 2017

2016-2019

1 reference

26 September 2017

12

1 reference

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

The role of thiols in cellular response to radiation and drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

1 reference

7 January 2021

High-dose intravenous melphalan: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Effects of glutathione depletion on the cytotoxicity of agents toward a human colonic tumour cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Melphalan-induced toxicity in nude mice following pretreatment with buthionine sulfoximine.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

A fluorescence digital image microscopy system for quantifying relative cell numbers in tissue culture plates

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

A fluorometric method for determination of oxidized and reduced glutathione in tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Role of glutathione in cellular resistance to alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

Ascorbic acid enhances the cytotoxic effect of 6-hydroxydopamine for human neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900203-7

7 January 2021

10.1016/S0959-8049(97)00203-7

Identifiers

DOI

1 reference

26 September 2017

1 reference